Effects of combined sildenafil-nitric oxide donor on defibrillation efficacy.

Simple item page
dc.contributor.authorShinlapawittayatorn, Krekwiten_US
dc.contributor.authorChattipakorn, Siripornen_US
dc.contributor.authorSungnoon, Rattapongen_US
dc.contributor.authorChattipakorn, Niponen_US
dc.date.accessioned2009-05-27T20:16:43Z
dc.date.available2009-05-27T20:16:43Z
dc.date.issued2007-10-29en_US
dc.descriptionChotmaihet Thangphaet.en_US
dc.description.abstractBACKGROUND: A previous study demonstrated that supra-therapeutic concentration of sildenafil citrate attenuates defibrillation efficacy. However, the effect of combined sildenafil and NTG administration on defibrillation efficacy is not known. OBJECTIVE: The present study investigated whether sildenafil administration at the therapeutic level increases the defibrillation threshold (DFT) when combined with NTG. MATERIAL AND METHOD: Twenty-four pigs (20-25 kg) were randomized into four groups. After the control DFT was obtained, a stock solution of 50-mg (group 1, therapeutic concentration) and 100-mg (group 2, supratherapeutic concentration) of sildenafil, and 100-mL of saline (groups 3 and 4) were infused at 2 mL/min. Then, NTG was administered in groups 1-3 at 5 microg/min, with an increment of 5 microg/min every 5 min. The DFT was determined again after NTG was infused for 20 minutes. RESULTS: In group 1, the DFT (402 +/- 33V, 11 +/- 2J) was not different from the control (404 +/- 28V, 11 +/- 2J). In group 2, the DFT (521 +/- 18V, 19 +/- 1J) was higher (p < 0.004) than that in the control group (444 +/- 31V, 14 +/- 2J). Saline did not alter the DFT either individually or in combination with NTG. CONCLUSION: Supratherapeutic dose of sildenafil-NTG combination significantly increased the DFT (17% of peak voltage, 37% of total energy). This effect on DFT appears to be driven by sildenafil and not NTG.en_US
dc.description.affiliationCardiac Electrophysiology Unit, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.en_US
dc.identifier.citationShinlapawittayatorn K, Chattipakorn S, Sungnoon R, Chattipakorn N. Effects of combined sildenafil-nitric oxide donor on defibrillation efficacy. Journal of the Medical Association of Thailand. 2007 Oct; 90(10): 2143-9en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/42700
dc.language.isoengen_US
dc.source.urihttps://www.mat.or.th/journal/all.phpen_US
dc.subject.meshAnimalsen_US
dc.subject.meshElectric Countershocken_US
dc.subject.meshHeart Ventricles --drug effectsen_US
dc.subject.meshHemodynamics --drug effectsen_US
dc.subject.meshMyocardiumen_US
dc.subject.meshNitric Oxide --pharmacologyen_US
dc.subject.meshNitroglycerin --pharmacologyen_US
dc.subject.meshPhosphodiesterase Inhibitors --pharmacologyen_US
dc.subject.meshPiperazines --pharmacologyen_US
dc.subject.meshPurines --pharmacologyen_US
dc.subject.meshSulfones --pharmacologyen_US
dc.subject.meshSwineen_US
dc.subject.meshVentricular Fibrillation --physiopathologyen_US
dc.titleEffects of combined sildenafil-nitric oxide donor on defibrillation efficacy.en_US
dc.typeJournal Articleen_US
dc.typeResearch Support, Non-U.S. Gov'ten_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Journal of the Medical Association of Thailand